SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-05-020682
Filing Date
2005-07-05
Accepted
2005-07-05 17:02:53
Documents
1
Group Members
MDS CAPITAL MANAGEMENT CORP.MDS LIFE SCIENCES TECHNOLOGY FUND II NC LIMITED PARTNERSHIPMDS LIFE SCIENCES TECHNOLOGY FUND II QUEBEC LIMITED PARTNERSMDS LSTF II (NCGP) INC.MDS LSTF II (QGP) INC.MICHAEL CALLAGHANML II CO-INVESTMENT FUND NC LIMITED PARTNERSHI

Document Format Files

Seq Description Document Type Size
1 v021066_sc13da.txt SC 13D/A 70943
  Complete submission text file 0001144204-05-020682.txt   73482
Mailing Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025 6504625900
DEPOMED INC (Subject) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53683 | Film No.: 05937737
SIC: 2834 Pharmaceutical Preparations

Mailing Address MDS CAPITAL CORP 100 INTERNATIONAL BLVD TORONTO ONTARIO CANA A6 0000
Business Address
MDS CAPITAL CORP (Filed by) CIK: 0001229595 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6
Type: SC 13D/A